reference/13332174

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13332174

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1109
issn	1365-2362 0014-2972
issueIdentifier	12
pageRange	1098-1109
publicationName	European Journal of Clinical Investigation
startingPage	1098
bibliographicCitation	Sillaber C, Herrmann H, Bennett K, Rix U, Baumgartner C, Böhm A, Herndlhofer S, Tschachler E, Superti-Furga G, Jäger U, Valent P. Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily. Eur J Clin Invest. 2009 Dec;39(12):1098–109. doi: 10.1111/j.1365-2362.2009.02206.x. PMID: 19744184.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2cac5f2cd85305ed504fe2759503a7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ee2f2c9e41621f5a47e486c26937b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6aa78684a2a9dc0f94c8a6087440c5fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f29c5d523e299efe2f18cab38af8235d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be03ced5ce9c8ca3045847f849f7b3eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d236cfd9032a28c5fdc560889bcd8127 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a59299464ccf2012d9f390cda1a7a5a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51cd745b5b9c75e662f1136da0ca83a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f24f2bb071f6f53a3c58fe5d08087bcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e69303f025b7af2d1ea222bcea58fc04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b92ef622152fa7393020e6d6b3d9003
date	2009-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19744184 https://doi.org/10.1111/j.1365-2362.2009.02206.x
isPartOf	https://portal.issn.org/resource/ISSN/0014-2972 https://portal.issn.org/resource/ISSN/1365-2362 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3611
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
discusses	http://id.nlm.nih.gov/mesh/M0001435 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0021333 http://id.nlm.nih.gov/mesh/M0011122 http://id.nlm.nih.gov/mesh/M0328053 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015464Q000276 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D008214Q000276 http://id.nlm.nih.gov/mesh/D000951Q000276 http://id.nlm.nih.gov/mesh/D013844Q000009 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D011743Q000009 http://id.nlm.nih.gov/mesh/D007166Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D001491Q000187 http://id.nlm.nih.gov/mesh/D007136Q000187 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D013844Q000008 http://id.nlm.nih.gov/mesh/D007136Q000097 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D008214Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D001491Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020543Q000032 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000951Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9245 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_564f64348efdade903a3b83a985759d0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5282077eb6f2e0ad7e7bc4da2627c39c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8900 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8322

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136

Total number of triples: 78.